[email protected]

Thank you to our 2019 Reviewers We would particularly like to thank the following individuals who are the top reviewers for the journal in 2019, all with >10 reviews:   Andrew Elders Alexander Cole Nathan Lawrentschuk Kelly Stratton Janet Baack Kukreja Stacy Loeb Robert H. Thompson Hashim Ahmed   We are extremely grateful to all our reviewers for their time and hard work Aastha Abboudi, Hamid Abdollah, Firas Abern, Michael Abufaraj,…

Maria Uloko is a Urology Resident at the University of Minnesota Hospital. In this podcast she discusses a recent Article of the month: Exercise‐induced attenuation of treatment side‐effects in patients with newly diagnosed prostate cancer beginning androgen‐deprivation therapy: a randomised controlled trial Abstract Objectives (i) To assess whether exercise training attenuates the adverse effects of treatment in patients with newly diagnosed prostate cancer beginning androgen‐deprivation…

Maria Uloko is a Urology Resident at the University of Minnesota Hospital. In this podcast she discusses a recent Article of the week: Health‐related quality of life among non‐muscle‐invasive bladder cancer survivors: a population‐based study Abstract Objective To examine the effect of non‐muscle‐invasive bladder cancer (NMIBC) diagnosis and treatment on survivors’ quality of life (QoL). Patients and Methods Of the 5979 patients with NMIBC diagnosed between 2010…

The first Article of the Month for 2020 is from work carried out at Northumbria University in Newcastle, Norfolk and Norwich University Hospital, both in the UK, and James Cook University in Queensland, Australia (Exercise-induced reduction of ADT side-effects in newly diagnosed PCa patients beginning androgen‐deprivation therapy: a randomised controlled trial). The article discusses the benefits of exercise in improving quality of life and reducing cardiovascular events following treatment for…

This blog marks the launch of the British Journal of Urology 90 years ago.  Since then the Journal has undergone many changes as urology and the publishing environment have changed. The first Editors outlined their vision in the Foreword of the first issue, which includes an introduction to the speciality, the locations and opening hours of Urology Clinics and a plea for peace: The British Journal of Urology Vol.1 1929 From the outset, the Editors placed emphasis on seeking collaboration…

IP4- CHRONOS is open! CHRONOS is a phase II randomised control trial, that will review the outcomes (including oncological, functional, quality of life and cost-effectiveness) of focal therapy against those from radical therapy, in men with newly diagnosed localised clinically significant prostate cancer.     All men newly diagnosed with low-intermediate risk prostate cancer, confined to the prostate, with a life expectancy of at least 10 years will be screened for eligibility.…